Goldman Sachs backs Amgen shares with Buy rating, emphasizing …

Jan 8, 2025 · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ:AMGN) shares. The firm's analyst, Salveen Richter, provided insights …

CouponFollow Extension

$370.00
OFF

Goldman Sachs Backs Amgen Shares With Buy Rating, Emphasizing …

2 weeks from now

Jan 8, 2025 · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ:AMGN) shares. The firm's analyst, Salveen Richter, provided insights …

investing.com

$370.00
OFF

Goldman Sachs Backs Amgen Shares With Buy Rating, Emphasizing …

2 weeks from now

Jan 8, 2025 · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ: AMGN) shares.The firm's analyst, Salveen Richter, provided insights …

investing.com

$370.00
OFF

Goldman Sachs Retains Amgen Buy Stock Rating On Clinical Trial

2 weeks from now

Jan 15, 2025 · On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ:AMGN), maintaining a price target of $370.00. The biotechnology giant, with a …

investing.com

$370.00
OFF

Goldman Sachs Retains Amgen Buy Stock Rating On Clinical Trial

2 weeks from now

Jan 15, 2025 · On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ: AMGN), maintaining a price target of $370.00.The biotechnology giant, with a …

investing.com

$369.00
OFF

Goldman Sachs Highlights Competitive Landscape For Amgen …

2 weeks from now

Oct 16, 2024 · On Wednesday, Goldman Sachs reiterated its Conviction Buy rating on Amgen (NASDAQ: AMGN), maintaining a price target of $369.00.The endorsement follows Amgen's …

investing.com

$370
OFF

Goldman Sachs Adjusts Price Target On Amgen To $370 From $375 ...

2 weeks from now

Jan 8, 2025 · Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating ... Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy …

marketscreener.com

$298.00
OFF

Goldman Sachs Reaffirms Their Buy Rating On Amgen (AMGN)

2 weeks from now

Apr 28, 2023 · In a report released today, Salveen Richter from Goldman Sachs maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $298.00.The company’s …

businessinsider.com

$270
OFF

Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To …

2 weeks from now

Dec 16, 2019 · Goldman has Buy ratings on all three stocks and a $270 price target on Amgen, a $330 price target on UnitedHealth and $66 price target on Dentsply Sirona. ... Goldman Sachs …

yahoo.com

$310.00
OFF

Piper Sandler Reaffirms Their Buy Rating On Amgen (AMGN)

2 weeks from now

Jan 17, 2025 · Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The company’s shares closed …

businessinsider.com

$370.00
OFF

Amgen News (AMGN) - Investing.com

2 weeks from now

Goldman Sachs backs Amgen shares with Buy rating, emphasizing value at current trading levels On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen …

investing.com

$370.00
OFF

Goldman Sachs Reiterates Buy Rating On Amgen (AMGN)

2 weeks from now

Jan 15, 2025 · Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $370.00 price target on Amgen (NASDAQ: AMGN)The analyst comments "We met with management, where …

streetinsider.com

$370.00
OFF

Goldman Sachs Reiterates Buy Rating On Amgen (AMGN)

2 weeks from now

Jan 8, 2025 · Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $370.00 price target on Amgen (NASDAQ: AMGN)The analyst comments "We note investor incoming on …

streetinsider.com

$310
OFF

Piper Sandler Maintains Amgen Stock Overweight With $310 Target …

2 weeks from now

Specifically, Goldman Sachs maintains a Buy rating, while RBC Capital Markets holds an Outperform rating. Piper Sandler also maintains an Overweight rating on Amgen, despite …

msn.com

$295
OFF

Are Wall Street Analysts Predicting Amgen Stock Will Climb Or Sink?

2 weeks from now

3 days ago · On Jan. 28, Citi lowered its price target on Amgen to $295, maintaining a “Neutral” rating due to a more challenging biotech sector outlook in 2025. As of writing, AMGN is trading …

nasdaq.com

$370
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

2 days ago · Lastly, Goldman Sachs maintained its Buy rating on Amgen stock with a price target of $370, following discussions with Amgen's management about the company's late-stage …

investing.com

$370
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

Lastly, Goldman Sachs maintained its Buy rating on Amgen stock with a price target of $370, following discussions with Amgen's management about the company's late-stage pipeline and …

msn.com

19%
OFF

Amgen Q4: Good Quarter, Ok Guidance, But MariTide Concerns …

2 weeks from now

1 day ago · Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year. Explore more details here.

seekingalpha.com

FAQs about Goldman Sachs backs Amgen shares with Buy rating, emphasizing … Coupon?

Is Amgen a good stock to buy?

Additionally, Amgen has reported robust revenue growth of 21.25% in the last twelve months. Analysts from Goldman Sachs and RBC Capital Markets have reiterated their positive ratings on Amgen's stock, emphasizing the company's potential for sustained growth through its established products and emerging pipeline. ...

Is salveen Richter a buy on Amgen?

In a report released today, Salveen Richter from Goldman Sachs maintained a Buy rating on Amgen ( AMGN – Research Report ), with a price target of $298.00. The company’s shares closed yesterday at $240.34. According to TipRanks, Richter is a 5-star analyst with an average return of 26.2% and a 50.92% success rate. ...

Why did Erste Group Upgrade Amgen shares from hold to buy?

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, which includes a higher operating margin and impressive 56% return on equity. ...

What is the volume of Amgen stock?

Currently, Amgen has an average volume of 2.45M. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. ...

Is Amgen a good stock to buy after introducing maritide?

Piper Sandler expressed confidence in Amgen's ability to maintain stability in its revenue and EBITDA at least until the end of the decade. The analysts anticipate that Amgen's growth could become more pronounced following the introduction of MariTide to the market. ...

Will Amgen's Savage drop in value lead to more sell-offs?

There are major data catalysts upcoming for the drug, but based on the savage drop in value of shares in November last year, we may speculate more bad news with be greeted with more sell-offs. Amgen key pipeline events (presentation) ...